Medical Device Regulatory Consulting Services

Cisema delivers specialized medical device consulting services for international clients looking to access the Chinese and Asia-Pacific markets. With a deep understanding of local regulations, we help medical device manufacturers navigate the full spectrum of regulatory compliance activities. Our bilingual consulting team, located across Europe and Asia, ensures timely, accurate, and fully compliant submission of all required regulatory documents.

Our services include registration, type testing, clinical research, post-market surveillance. Whether you're a digital health startup or a blue-chip in the medical device industry, Cisema offers hands-on support and strategic guidance tailored to your product type—covering devices, combination products, and more.

We go beyond medical device regulatory affairs. As one of the few consulting firms with cross-sector capabilities, we also serve related areas within the healthcare industry such as IVDs, pharmaceuticals, biopharma, cosmetics, health foods, veterinary medicines, and consumer goods. Our integrated approach allows clients to manage compliance across multiple verticals through one trusted partner.

Medical Device Consultant - Cisema
Outsourcing service

Discover our China Medical Device Consulting Services

Whether you’re just starting out or are a blue-chip, access our wide range of services and solutions to help your business thrive in China.

NMPA Legal Agent

We act as your official representative in China, handling registrations, filings, and ensuring you are fully compliant, including quality assurance and PMS requirements.

Learn more

NMPA Type Testing

We provide end-to-end support for China type testing in NMPA-accredited laboratories. Our experienced test engineers offer on-site supervision to guarantee accurate and reliable results.

Learn more

China Clinical Trials

You may be required to provide supplementary clinical data on Chinese patients or conduct a full clinical trial in China.Our clinical research consultants will advise you, prepare the study protocol and assist setting up the clinical trial in China.

Learn more

NMPA Clinical Evaluation Report

CERs can avoid the need for a China clinical trial in some instances. Our experts can advise and prepare NMPA-compliant CERs.

Learn more

Drug Device Combination Products

We assist with the classification, registration, and compliance of combination products in China, whether drug or device-led.

Learn more

China Medical Device Quality Compliance

We help you achieve and ensure ongoing compliance with Chinese requirements.Our experts prepare and assist you for official NMPA inspections.

Learn more

Medical Device PMS & Vigilance

The NMPA is placing greater focus on Post-Market Surveillance (PMS) such as more in-market sampling inspections and regular standard changes.Our specialist PMS team means you remain fully compliant at all tims.

Learn more

Regulatory Outsourcing

Leverage our team of consultants and subject matter experts for specialized projects or long-term regulatory resource needs.

Learn more
Medical Device Consultant

Our Hong Kong Medical Device 
Consulting Services

Our Hong Kong Medical Device Consulting Services provide targeted support to help you meet regulatory requirements and launch your products with confidence.

Hong Kong Local Responsible Person

We act as your designated Local Responsible Person (LRP), fulfilling listing and PMS obligations under MDACS.

Learn more

Hong Kong IVD Registration

We support you through every stage of the Hong Kong IVD Listing process. From classification to handling regulatory requirements, we make the process as smooth as possible.

Learn more

Regulatory Outsourcing

If you are seeking specific specialist expertise or have ongoing resource-intensive needs, our team of consultants has a variety of solutions to meet your needs.

Learn more

Discover Our Other Medical Device Consulting Services Across APAC

Malaysia

Singapore

Vietnam

Taiwan

Indonesia

The Philippines

Thailand

Useful Articles

View More

China’s 15th Five-Year Plan: Implications for Drugs, Medical Devices, & Market Access 

China’s 15th Five-Year Plan signals stronger support for innovative drugs, advanced medical devices, reimbursement reform, and NMPA regulatory pathways.

May 8, 2026
China’s 15th Five-Year Plan: Implications for Drugs, Medical Devices, & Market Access 
Chinese flag against a blue sky

Breaking Into Southeast Asia’s Dental Market: 3 Things Manufacturers Need to Get Right

Enter Southeast Asia’s dental market with a clear strategy: navigate regulatory complexity, sequence market entry, and retain control of registrations to scale efficiently.

May 6, 2026
Breaking Into Southeast Asia’s Dental Market: 3 Things Manufacturers Need to Get Right
Malaysian dentist with a patient in a well lit dental clinic.

Entering China’s Intraocular Lens (IOL) Market: NMPA Registration Requirements for Foreign Manufacturers

Understand the pathway for intraocular lens (IOL) registration in China, including NMPA requirements and key compliance steps.

April 29, 2026
Entering China’s Intraocular Lens (IOL) Market: NMPA Registration Requirements for Foreign Manufacturers
A close-up of an eye with a transparent intraocular lens held by surgical tweezers positioned in front of the pupil, illustrating ophthalmic medical device use. The visual supports themes of regulatory compliance, product registration, and market access

China Hyaluronic Acid Registration: A Complete Guide

A complete guide to China hyaluronic acid registration, covering classification, NMPA requirements, and compliance steps for manufacturers.

April 27, 2026
China Hyaluronic Acid Registration: A Complete Guide
China Hyaluronic Acid Registration: A Complete Guide

China Medical Device Approval Tracker: Imported Class II & III Devices

Track all imported Class II and III medical device approvals in China with this monthly updated NMPA submission tracker.

April 23, 2026
China Medical Device Approval Tracker: Imported Class II & III Devices
Graph showing 2026 data for China Class II and Class III medical device approvals

Malaysia Drug–Medical Device Combination Products: A Guide to Classification & Regulatory Pathways

Learn how Malaysia classifies drug–medical device combination products and how the PMOA determines pathways and compliance responsibilities.

April 23, 2026
Malaysia Drug–Medical Device Combination Products: A Guide to Classification & Regulatory Pathways
Laboratory professional in protective eyewear, hair cover, sterile gown, and blue nitrile gloves examining a filled syringe in a clean laboratory environment.
Previous
Previous

Other Industries We Support

In addition to medical devices, we offer consulting services across regulated industries including IVDs, pharmaceuticals, biopharma, cosmetics, health foods, veterinary products, and other industrial and consumer goods. Our team ensures tailored regulatory compliance strategies, regardless of product category or manufacturing model.

How We’ve Helped Clients with Our Expert Guidance

Read about how we work with clients to find solutions, bringing together deep industry knowledge with leading talent.

View More
Previous
Previous

Latest Insights

View More

Hong Kong Clarifies Injectable Products Are Regulated as Pharmaceutical Products Under Cap. 138

Hong Kong confirms injectable products are generally classified as pharmaceutical products under Cap. 138, impacting medical aesthetics and borderline products

May 8, 2026
Hong Kong Clarifies Injectable Products Are Regulated as Pharmaceutical Products Under Cap. 138
Minimalist, well-lit medical aesthetics clinic in Hong Kong. An Asian female doctor in a simple white coat and disposable gloves sits beside a female patient, holding a single unbranded prefilled syringe at chest level.

CMDE Unveils 2026–2027 Roadmap for Medical Device Registration Guidelines, Emphasizing AI, IVDs, and High-Risk Technologies

CMDE maps 275 guideline updates, tightening requirements and giving manufacturers early visibility for planning and compliance.

May 5, 2026
CMDE Unveils 2026–2027 Roadmap for Medical Device Registration Guidelines, Emphasizing AI, IVDs, and High-Risk Technologies
dermatology treatment room in a modern Chinese hospital, medium shot: a licensed clinician in medical scrubs and protective eyewear performing a laser skin procedure using a professional Nd:YAG laser system

China’s New AI Ethics Measures Increase Scrutiny of High-Impact AI, Including Health-Related Technologies

China’s MIIT and nine ministries introduce a new AI ethics review and services framework establishing tiered oversight, compliance obligations, and governance pathways for AI activities in China.

April 28, 2026
China’s New AI Ethics Measures Increase Scrutiny of High-Impact AI, Including Health-Related Technologies

China Tightens Medical Device Post-Market Surveillance with New Risk Evaluation and Report Review Rules

China issues new guidelines on medical device adverse event risk evaluation and periodic report review, tightening post-market surveillance requirements

April 27, 2026
China Tightens Medical Device Post-Market Surveillance with New Risk Evaluation and Report Review Rules
Clinician adjusts IV pump in hospital room while colleague records data, illustrating medical device use and compliance.

New NMPA Guideline Defines Registration Requirements for IVUS Systems and Catheters

China’s CMDE releases a new IVUS registration review guideline, defining technical, clinical, and testing requirements for NMPA medical device registration

April 27, 2026
New NMPA Guideline Defines Registration Requirements for IVUS Systems and Catheters

Malaysia Introduces New e-IFU & Digital Labelling Guidance for Medical Devices

Malaysia’s MDA publishes the 7th edition of guidance on medical device labelling, with new e-labelling, e-IFU, and accessibility requirements

April 23, 2026
Malaysia Introduces New e-IFU & Digital Labelling Guidance for Medical Devices
Two professionals in an office review documentation for a HealthScreen glucose monitor while examining a computer display showing a product label with model number, barcode, and QR code. One person points to the code on the screen as the other reads.
Previous
Previous

Get in Touch with Our Medical Device Consultants

Speak to our consultants to learn how our comprehensive services, regulatory guidance, and operational expertise can help you stay ahead in the complex medical device regulatory environment of China and Southeast Asia.

Request Proposal